Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
toxicities, neuron-glia interactions, genetics and epigenetics will provide insights in identifying novel biomarkers and drug targets. Expand and improve skills: disease models based on genome-modified animals
-
of seed gene networks”. This project aims to use reverse genetics, cross-species complementation and single cell next-generation sequencing approaches to investigate how the gene networks that regulate
-
fluorescence microendoscopy Fiber photometry & optogenetics Genetically encoded molecular tools We focus on behaviors such as reward learning, fear learning and motor learning, with strong interest in primary
-
; perform downstream bioinformatic analysis using appropriate tools (e.g., Seurat, Scanpy, Cell Ranger). • Analyze whole genome sequencing data sets • Collaborate with clinicians, computational biologists
-
of medicine through cutting-edge research. Leveraging multiomics, mouse genetics, hiPS cells, and electrophysiology, our lab works on molecular mechanism of cardiometabolic oncology. The postdoctoral fellow
-
development? and ii) Why does this morphogenesis go awry in vascular diseases? We apply developmental biology, genetic, biochemical, and omics approaches to uncover key insights into the morphogenesis and
-
interspecies chemical signalling bacteria/fungus-virus interactions in the soil soil microbiology microbial community modelling and plant genetics in the context of microbial interactions. This position will
-
. This collaboration fosters a strong interdisciplinary environment across institutions, leveraging complementary expertise in statistical genetics, biomedical data integration, and computational method development
-
. The development of novel immunologic techniques and applying novel technologies will be included in this effort. Collaboration with pathologists for correlations with tissue imaging and with computational
-
genetic screen (e.g., metabolic pathway, mitochondria structure) 2) Understanding the role of innate immunity during leukemogenesis as well as disease relapse in order to design novel inhibitors